The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma
J Best, H Bilgi, D Heider, C Schotten… - Zeitschrift für …, 2016 - thieme-connect.com
Background: Hepatocellular carcinoma (HCC) is one of the leading causes of death in
cirrhotic patients worldwide. The detection rate for early stage HCC remains low despite …
cirrhotic patients worldwide. The detection rate for early stage HCC remains low despite …
[HTML][HTML] The evolution of the use of serum alpha-fetoprotein in clinical liver cancer surveillance
SL Kelly, TG Bird - Journal of immunobiology, 2016 - ncbi.nlm.nih.gov
Liver cancer is the 6 th most common cancer and 2 nd leading cause of cancer-related
mortality. In order to improve patient survival early tumor detection is required and this …
mortality. In order to improve patient survival early tumor detection is required and this …
Molecular diagnostics in cancer
ZL Coyne, RD Kalachand, RC Bast Jr… - Holland‐Frei Cancer …, 2016 - Wiley Online Library
Overview Molecular diagnostics refers to the use of molecular alterations that are associated
with cancers to facilitate detection, diagnosis, monitoring, and/or treatment selection …
with cancers to facilitate detection, diagnosis, monitoring, and/or treatment selection …
Übersicht–Systemische Therapie des hepatozellulären Karzinoms
A Vogel, MM Kirstein - TumorDiagnostik & Therapie, 2016 - thieme-connect.com
Das hepatozelluläre Karzinom (HCC) ist weltweit der siebthäufigste Tumor (fünfthäufigste
bei Männern, achthäufigste bei Frauen). Aufgrund der anhaltend unzureichenden …
bei Männern, achthäufigste bei Frauen). Aufgrund der anhaltend unzureichenden …